OXA1 Antibody

What is OXA1L protein and what is its cellular function?

OXA1L (Oxidase Assembly 1-Like) is a member of the conserved Oxa1/YidC/Alb3 protein family required for cytochrome c oxidase assembly. It functions primarily as a mitochondrial inner membrane protein with a predicted five-transmembrane segment (TM1~5) topology . The protein has a distinctive structure where the N-terminus and a hydrophilic loop (L2) are exposed to the intermembrane space, while the C-terminal region and two loops (L1 and L3) are exposed to the matrix .

Functionally, OXA1L mediates the insertion of mitochondrial DNA-encoded subunits of respiratory complexes and several nuclear DNA-encoded proteins into the inner membrane from the matrix . The protein plays a critical role in maintaining mitochondrial function through its insertase activity, facilitating the proper assembly of the electron transport chain components.

What applications are validated for OXA1L antibodies?

OXA1L antibodies have been validated for multiple research applications as evidenced by published literature. The primary applications include:

These applications have been documented across multiple published studies, with Western blotting being the most widely reported application with at least 9 publications referencing its use .

What is the molecular weight of OXA1L and how does this affect antibody selection?

OXA1L has a calculated molecular weight of 49 kDa (437 amino acids) but is typically observed at approximately 42 kDa in experimental conditions . This discrepancy between calculated and observed weights is important to consider when interpreting Western blot results.

When selecting an OXA1L antibody, researchers should verify that the antibody can detect the mature processed form of the protein. Studies have shown that rOxa1-HA (rat OXA1 with an HA tag) is synthesized as a preprotein with a size approximately 6.8 kDa higher than the mature form . This processing appears to occur between amino acid residues 64 and 65 . Therefore, antibodies targeting different epitopes may show varying band patterns depending on whether they recognize the preprotein, mature protein, or both forms.

How does the topogenesis of OXA1L affect its function and experimental detection?

The topogenesis of OXA1L is complex and directly impacts both its functional activity and experimental detection strategies. Studies have revealed several critical aspects of OXA1L topogenesis:

First, the N-terminal 64-residue segment functions as a presequence or mitochondrial targeting signal (MTS). Deletion experiments have demonstrated that removing this segment redirects the mature protein to the endoplasmic reticulum, indicating that the presequence arrests cotranslational activation of potential ER-targeting signals within mature OXA1L .

Second, systematic deletion studies of OXA1 transmembrane segments have revealed that all five TMs are essential for efficient membrane integration . This structural requirement has significant implications for experimental designs targeting OXA1L function, as mutations or truncations may compromise membrane integration.

For detection strategies, researchers should consider:

• The N-terminal portion (71 residues) of mammalian OXA1 is exposed to the mitochondrial intermembrane space (IMS)

• The C-terminal segment localizes in the matrix

• Proteinase K treatment of intact mitochondria produces an antibody-detectable fragment that can be used as a measure of proper membrane integration

These topological features are critical when designing epitope tagging experiments or interpreting antibody binding patterns in various subcellular fractionation assays.

What are the critical experimental conditions for studying OXA1L insertion mechanism?

OXA1L forms a voltage- and substrate-dependent membrane pore that is essential for its function as a protein insertase . When investigating this mechanism, researchers should consider several critical experimental parameters:

• Membrane potential maintenance: Since OXA1L activity is voltage-dependent, experiments should control and monitor membrane potential. In knockdown studies, researchers have used MitoTracker Red staining and fluorescence-activated cell sorting to confirm that mitochondrial membrane potential remains intact despite OXA1 reduction .

• Protein extraction conditions: OXA1L is firmly inserted into the mitochondrial inner membrane and is resistant to alkaline extraction. Experimental protocols should use appropriate detergent conditions:

  • 1% Triton X-100 for complete digestion of OXA1L by proteinase K

  • Gradient concentrations of digitonin for selective permeabilization of the outer membrane while maintaining inner membrane integrity

• Expression systems: For recombinant expression, His-tagged OXA1 has been successfully expressed in E. coli BL21(DE3) cells with specific conditions:

  • Growth at 30°C in Terrific Broth medium with kanamycin

  • Induction with 0.5 mM ISOPROPYL-1-thio-β-D-galactopyranoside

  • Expression for 4 hours at 30°C

These conditions provide a foundation for investigating the biophysical and functional properties of the OXA1L insertase mechanism.

How do knockdown studies of OXA1L inform our understanding of its function, and what are the technical considerations?

Knockdown studies have provided valuable insights into OXA1L function while revealing important species-specific differences. When designing OXA1L knockdown experiments, researchers should consider:

• The steady-state level of cytochrome c oxidase subunit II was not affected by OXA1L knockdown

• Cytochrome c oxidase subunit II remained resistant to alkaline extraction

• Mitochondrial membrane potential was not altered by the knockdown

These findings suggest potential compensatory mechanisms in mammals that are absent in yeast, highlighting the importance of species-specific experimental design. When conducting knockdown studies, researchers should:

• Validate knockdown efficiency using both Western blotting and immunofluorescence microscopy

• Monitor mitochondrial function using membrane potential indicators

• Assess the integration status of known OXA1L substrates through alkaline extraction resistance

• Consider longer knockdown periods or complete knockout approaches to overcome potential compensatory mechanisms

What are the optimal protocols for using OXA1L antibodies in Western blotting?

For optimal Western blot results with OXA1L antibodies, researchers should follow these methodological guidelines:

• Sample preparation:

  • For cell lines: HepG2, HeLa, NIH/3T3, and L02 cells have been validated for OXA1L detection

  • For tissue samples: Mouse and rat liver tissues have shown reliable OXA1L expression

  • Use standard lysis buffers containing protease inhibitors to prevent degradation

• Antibody selection and dilution:

  • Use anti-OXA1L antibodies at dilutions between 1:2000-1:10000 for Western blotting

  • Consider antibody #21055-1-AP which has been validated in multiple publications

• Expected results:

  • The calculated molecular weight of OXA1L is 49 kDa (437 amino acids)

  • The observed molecular weight is typically 42 kDa

  • When using tagged constructs (e.g., HA-tagged OXA1L), expect a slight shift in molecular weight

  • For precursor forms, an additional band approximately 6.8 kDa larger may be visible

• Controls and validation:

  • Include positive controls from validated cell lines

  • For knockdown studies, siRNA-treated samples can serve as negative controls

  • If studying tagged constructs, antibodies against the tag (e.g., anti-HA) can provide additional validation

The titration of antibody concentration is recommended for each testing system to obtain optimal signal-to-noise ratio, as sensitivity may vary depending on the expression level in different sample types .

What are the recommended protocols for immunofluorescence detection of OXA1L?

For successful immunofluorescence detection of OXA1L, researchers should implement the following protocol:

• Sample preparation:

  • HepG2 cells have been specifically validated for IF/ICC detection of OXA1L

  • For mitochondrial colocalization studies, MitoTracker Red can be used prior to fixation

  • For transfection experiments, allow 24-hour incubation after transfection before fixation

• Antibody dilution and incubation:

  • Use anti-OXA1L antibodies at dilutions between 1:400-1:1600 for IF/ICC applications

  • For sequential labeling with other mitochondrial markers, consider using antibodies against Tim23 or Tim44 as matrix markers

  • For ER colocalization studies, anti-calnexin antibody can be used as an ER marker

• Detection and visualization:

  • Use appropriate fluorescent secondary antibodies (fluorescein-labeled or Texas Red-labeled)

  • For co-localization studies, ensure spectral separation between fluorophores

  • Use confocal microscopy for optimal resolution of mitochondrial structures

• Expected results and analysis:

  • OXA1L should show punctate or tubular staining patterns consistent with mitochondrial localization

  • For wild-type OXA1L, expect co-localization with MitoTracker Red

  • For N-terminal deletion mutants (e.g., OXA1LΔ(1-64)), mislocalization to the ER may be observed

This protocol has been successfully applied to study both endogenous OXA1L and various tagged or mutant constructs in mammalian cells.

How can researchers troubleshoot issues with OXA1L antibody specificity and cross-reactivity?

When encountering problems with OXA1L antibody specificity or cross-reactivity, researchers should consider these troubleshooting approaches:

• Validation of specificity:

  • Knockdown/knockout controls: Use siRNA or CRISPR/Cas9 approaches to reduce OXA1L expression as negative controls. A successful knockdown should show approximately 80% reduction in signal after 48 hours

  • Recombinant protein controls: Express tagged versions of OXA1L (e.g., HA-tagged or T7-tagged constructs) to confirm antibody recognition patterns

  • Expected molecular weight verification: Confirm that the observed band matches the expected 42 kDa size for mature OXA1L

• Cross-reactivity assessment:

  • Test antibody reactivity across multiple species: OXA1L antibodies have demonstrated reactivity with human, mouse, and rat samples

  • Species-specific considerations: While the antibody shows cross-reactivity, there may be variations in signal intensity between species

• Optimization strategies:

  • Adjust antibody concentration: Titrate between the recommended ranges (1:2000-1:10000 for WB; 1:50-1:500 for IHC; 1:400-1:1600 for IF/ICC)

  • Modify blocking conditions: Test different blocking reagents (BSA, milk, commercial blockers) to reduce non-specific binding

  • Antigen retrieval for IHC: Use TE buffer pH 9.0 as the primary recommendation, or alternatively, citrate buffer pH 6.0

• Application-specific considerations:

  • For subcellular fractionation studies, include controls for mitochondrial enrichment

  • For protease protection assays, carefully control digitonin concentrations to selectively permeabilize the outer mitochondrial membrane

  • For membrane integration studies, use alkaline extraction to distinguish between membrane-integrated and peripheral proteins

By systematically applying these troubleshooting strategies, researchers can optimize OXA1L antibody performance across different experimental applications.

What are the critical controls needed when studying OXA1L protein interactions?

When investigating OXA1L protein interactions, comprehensive controls are essential to ensure valid and reproducible results:

• Subcellular fractionation controls:

  • Mitochondrial purity markers: Use antibodies against known mitochondrial proteins (Tim23, Tim44) to confirm mitochondrial enrichment

  • ER contamination markers: Test for calnexin to exclude ER contamination

  • Cytosolic markers: Include controls for cytosolic contamination of mitochondrial fractions

• Immunoprecipitation controls:

  • Input controls: Always analyze a portion of the starting material

  • Isotype controls: Use non-specific IgG matching the host species of the OXA1L antibody

  • Bead-only controls: Include samples processed without antibody addition

  • Reciprocal IP: When studying interactions, confirm by IP with antibodies against the putative interacting partner

• Membrane integration controls:

  • Alkaline extraction: OXA1L is resistant to alkaline extraction, confirming its status as an integral membrane protein

  • Protease protection assays: Use digitonin titration to selectively permeabilize the outer membrane while leaving the inner membrane intact

  • Detergent controls: Include 1% Triton X-100 conditions to demonstrate complete protein accessibility

• Protein-protein interaction specificity controls:

  • Competitive binding: Use recombinant fragments or peptides of OXA1L to demonstrate specificity

  • Deletion constructs: Create systematic deletions of OXA1L domains to map interaction surfaces

  • Negative controls: Include proteins not expected to interact with OXA1L

Implementation of these controls will help distinguish genuine interactions from experimental artifacts and provide confidence in the biological significance of observed interactions.

How should researchers design experiments to study the membrane pore properties of OXA1L?

To effectively study the membrane pore properties of OXA1L, researchers should design experiments that address its voltage- and substrate-dependent characteristics :

• Protein expression and purification:

  • Express His-tagged OXA1L in E. coli BL21(DE3) cells

  • Grow cultures at 30°C in Terrific Broth medium with kanamycin

  • Induce expression with 0.5 mM isopropyl 1-thio-β-D-galactopyranoside for 4 hours at 30°C

  • Include purification buffer containing 10 mM Tris (pH 7.0), 1 mM EDTA, 15% glycerol, and protease inhibitors (1 mM PMSF)

• Electrophysiological characterization:

  • Use planar lipid bilayer electrophysiology to directly measure channel activity

  • Apply different voltage potentials to assess voltage dependence

  • Monitor current changes that indicate channel opening and closing events

  • Calculate conductance and ion selectivity parameters

• Substrate interaction studies:

  • Test channel properties in the presence and absence of known substrate peptides

  • Monitor changes in gating behavior or conductance when substrates are present

  • Use peptides representing different regions of known OXA1L substrates to map interaction sites

• Critical parameters to measure:

  • Channel conductance under different voltage conditions

  • Ion selectivity of the pore

  • Gating kinetics (open probability, mean open/closed times)

  • Effects of pH, temperature, and ionic strength on channel properties

  • Substrate concentration-dependent effects on channel activity

These experimental approaches provide a comprehensive framework for characterizing the biophysical properties of the OXA1L insertase pore, yielding insights into its mechanism of action during protein insertion into the mitochondrial inner membrane.

What considerations are important when interpreting OXA1L knockdown or knockout phenotypes across different model systems?

Interpreting OXA1L knockdown or knockout phenotypes requires careful consideration of several factors that may influence experimental outcomes across different model systems:

• Species-specific differences:

  • In yeast, Oxa1 deletion severely impacts cytochrome c oxidase assembly and function

  • In mammalian cells, OXA1L knockdown does not significantly affect cytochrome c oxidase subunit II levels or membrane integration

  • These differences suggest potential compensatory mechanisms or functional redundancy in mammals

• Knockdown efficiency assessment:

  • RNA interference typically achieves approximately 80% reduction in OXA1L protein levels after 48 hours

  • This incomplete knockdown may allow residual OXA1L to maintain essential functions

  • Consider longer knockdown periods or complete knockout approaches to overcome potential threshold effects

• Timing of phenotype emergence:

  • Some phenotypes may require multiple cell divisions to become apparent

  • Mitochondrial proteins often have long half-lives, necessitating extended observation periods

  • Analysis at multiple time points post-knockdown/knockout is recommended

• Functional assays beyond protein levels:

  • Membrane potential measurements (e.g., using MitoTracker Red)

  • Respiratory complex activity assays

  • Protein synthesis and import assays to directly measure OXA1L-dependent processes

  • Electron microscopy to assess mitochondrial ultrastructural changes

• Cell type considerations:

  • Different cell types have varying energetic demands and mitochondrial content

  • High-energy-demanding tissues (heart, muscle, neurons) may show more pronounced phenotypes

  • Consider testing multiple cell types when available

By addressing these considerations, researchers can develop more nuanced interpretations of OXA1L function across evolutionary diverse systems and avoid potential pitfalls in experimental design and data analysis.

How can researchers reconcile differences between calculated and observed molecular weights of OXA1L?

The discrepancy between the calculated molecular weight of OXA1L (49 kDa) and its observed molecular weight in experimental systems (42 kDa) presents an important data interpretation challenge. Researchers can address this using several approaches:

• Processing verification:

  • Compare in vivo and in vitro expressed forms to identify potential processing events

  • Studies have shown that rOxa1-HA is synthesized as a preprotein with a size approximately 6.8 kDa higher than the mature form

  • Deletion constructs suggest that processing occurs between amino acid residues 64 and 65

• Post-translational modification analysis:

  • Investigate potential post-translational modifications that might alter migration patterns

  • Consider phosphorylation, acetylation, or other modifications that could affect protein mobility

  • Use phosphatase or deacetylase treatments to test these possibilities

• Structural considerations:

  • The hydrophobic nature of transmembrane proteins can cause anomalous migration on SDS-PAGE

  • The five transmembrane domains of OXA1L may bind SDS differently than standard globular proteins

  • Consider using alternative gel systems optimized for membrane proteins

• Experimental validation approaches:

  • Use mass spectrometry to determine the exact mass of the mature protein

  • Create N-terminal deletion constructs that mimic the mature form and compare migration patterns

  • Employ epitope tags at different positions to map the processed regions

By systematically addressing these factors, researchers can resolve the apparent molecular weight discrepancy and ensure accurate interpretation of Western blot and other protein analysis data.

What approaches can resolve contradictory results between different detection methods for OXA1L?

When faced with contradictory results between different detection methods for OXA1L, researchers should implement a systematic troubleshooting approach:

• Method-specific considerations:

  • Western blotting: Sensitivity to denaturation conditions; relies on antibody access to linear epitopes

  • Immunofluorescence: Depends on fixation methods and epitope accessibility in native conformation

  • Immunoprecipitation: Affected by detergent choice and interaction strength

  • Immunohistochemistry: Influenced by fixation, embedding, and antigen retrieval conditions

• Antibody-related factors:

  • Epitope location: Different antibodies may recognize distinct regions of OXA1L

  • Sensitivity to protein modifications: Some epitopes may be masked by post-translational modifications

  • Cross-reactivity profiles: Validate specificity using knockout/knockdown controls

  • Concentration optimization: Each method requires different optimal antibody dilutions

• Sample preparation variables:

  • Fixation effects: Paraformaldehyde versus methanol fixation can yield different results in IF

  • Extraction conditions: Detergent type and concentration affect membrane protein solubilization

  • Buffer compatibility: Some buffers may interfere with antibody binding

• Validation strategies:

  • Use multiple antibodies targeting different epitopes

  • Employ tagged constructs and detect with both anti-tag and anti-OXA1L antibodies

  • Implement orthogonal detection methods (e.g., mass spectrometry)

  • Include appropriate positive and negative controls for each method

By systematically evaluating these factors, researchers can identify the source of contradictory results and develop a coherent experimental approach that yields consistent data across multiple detection platforms.

How should researchers interpret OXA1L localization data in the context of mitochondrial dynamics?

Interpreting OXA1L localization data requires consideration of the dynamic nature of mitochondria and their subcompartments:

• Mitochondrial fusion and fission effects:

  • Mitochondrial morphology varies between cell types and physiological states

  • Fusion/fission dynamics can alter the apparent distribution of inner membrane proteins

  • Time-lapse imaging with OXA1L-fluorescent protein fusions can help track dynamic changes

• Submitochondrial localization precision:

  • OXA1L has a complex topology with the N-terminus exposed to the intermembrane space and C-terminus in the matrix

  • Super-resolution microscopy may be required to accurately resolve submitochondrial compartments

  • Electron microscopy with immunogold labeling can provide higher resolution localization data

• Colocalization analysis considerations:

  • Use markers for different mitochondrial compartments:

    • Outer membrane: TOM20, VDAC

    • Intermembrane space: Cytochrome c

    • Inner membrane: Tim23, Complex III components

    • Matrix: HSP60, mtHSP70

  • Quantitative colocalization metrics (Pearson's coefficient, Manders' overlap) should be calculated

  • Z-stack confocal imaging is essential for accurate 3D assessment

• Physiological state influences:

  • Respiratory state changes can alter cristae structure and protein distribution

  • Stress conditions may trigger changes in mitochondrial morphology

  • Cell cycle phase can impact mitochondrial organization

• Technical considerations for accurate interpretation:

  • Fixation artifacts: Different fixatives can alter mitochondrial morphology

  • Live versus fixed imaging: Consider dynamics versus resolution trade-offs

  • Antibody accessibility: Factors affecting membrane permeabilization can influence staining patterns

By addressing these considerations, researchers can develop more accurate and physiologically relevant interpretations of OXA1L localization data, particularly in the context of dynamic mitochondrial processes and disease states.

What are the emerging techniques for studying OXA1L function beyond traditional antibody applications?

Several cutting-edge approaches are expanding our understanding of OXA1L biology beyond conventional antibody-based methods:

• CRISPR-based approaches:

  • Genome editing for complete knockout studies rather than transient knockdown

  • CRISPR interference (CRISPRi) for tunable and reversible repression

  • CRISPR activation (CRISPRa) for controlled overexpression

  • Knock-in of fluorescent tags at endogenous loci for physiological expression levels

• Advanced imaging techniques:

  • Super-resolution microscopy (STORM, PALM, STED) for precise submitochondrial localization

  • Live-cell imaging with split fluorescent protein complementation to visualize protein interactions

  • Correlative light and electron microscopy (CLEM) to connect ultrastructure with protein localization

  • Light sheet microscopy for long-term, low-phototoxicity mitochondrial dynamics studies

• Proximity labeling methods:

  • BioID or TurboID fusion proteins to identify proximal interacting partners

  • APEX2 for electron microscopy-compatible proximity labeling

  • Split-BioID for conditional interaction-dependent labeling

• Biophysical approaches:

  • Reconstitution of purified OXA1L into liposomes for functional studies

  • Planar lipid bilayer electrophysiology to characterize channel properties

  • Single-molecule FRET to study conformational dynamics during substrate insertion

These emerging technologies provide complementary approaches to antibody-based detection methods and offer new insights into OXA1L function, regulation, and interactions within the complex mitochondrial environment.

How can OXA1L research inform broader understanding of mitochondrial disease mechanisms?

Research on OXA1L has significant implications for understanding mitochondrial disease mechanisms through several pathways:

• Respiratory chain assembly defects:

  • OXA1L mediates insertion of critical components of respiratory complexes

  • Dysfunction could contribute to energy production deficits in mitochondrial diseases

  • Understanding the regulatory mechanisms may reveal therapeutic targets for improving assembly efficiency

• Protein quality control interactions:

  • OXA1L likely interacts with mitochondrial quality control systems

  • Investigation of these interactions could reveal how cells manage defective respiratory complex assembly

  • The role of OXA1L in protein homeostasis may inform broader quality control mechanisms relevant to neurodegenerative diseases

• Species-specific compensation mechanisms:

  • The surprising resilience of mammalian cells to OXA1L knockdown compared to yeast suggests compensatory mechanisms

  • Identifying these mechanisms could reveal novel therapeutic targets for mitochondrial diseases

  • Comparative studies across species may uncover evolutionary adaptations in mitochondrial biogenesis

• Mitochondrial membrane organization:

  • OXA1L's role in organizing the inner membrane may impact cristae structure

  • Cristae remodeling is implicated in apoptosis and various pathological conditions

  • Understanding these connections could link OXA1L to broader cell death and disease mechanisms